PGRMC1 and breast cancer: The expression of a heme-binding defective PGRMC1 mutant and the resulting increased susceptibility of breast cancer cells to chemotherapeutic agents evidences a role for holo-PGRMC1 in regulating susceptibility to DNA damaging agents, similarly to its yeast homolog Dap1 [147].